Alphaken-c / Alfacalcidol 0.25 Mcg + El Calcium 200 Mg
Product Details :
Alphaken-C is indicated in
- Management of hypocalcaemia in patients undergoing dialysis for chronic renal failure. It has been shown to significantly reduce elevated parathyroid hormone (PTH) levels. Reduction of PTH has been shown to result in an improvement in renal osteodystrophy
- Post-menopausal osteoporosis.
- Hypocalcaemia in hypoparathyroidism
- Parathyroidectomy
- Vitamin D dependent rickets
- Renal tubular osteocalcaemia
- Sporadic and oncogenic hypophosphatemic osteomalacia
- X-linked hypophosphatemic osteomalacia
- Osteomalacia in Malabsorption syndrome
- Hypocalcaemia and hypomagnesaemia after small bowel resection
- Osteoporosis in males
- Psoriasis
